Jonas Schäfer

4PUBLICATIONS
28CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 18, 2024
Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy.

Fabian Acker, Jörg Chromik, Emily Tiedjen

|Sep 23, 2022
Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board.

Thomas S Tarawneh, Fiona R Rodepeter, Julia Teply-Szymanski

|Jul 06, 2022
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.

Kai Rejeski, Andreas Burchert, Gloria Iacoboni

|Apr 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial.

Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh

Pageof 1

Frequent Collaborators

2 joint publications

Marion Subklewe

1 joint publications

Marina Y Konopleva

1 joint publications

Christoph Röllig

1 joint publications

Larisa Girshova